Is the Little Pink Pill Headed for American Bedrooms?
Sensuality News| Boehringer Ingelheim comes before the FDA in June 2010, to launch their application for approval their new female desire drug. We explore the pros and cons of the little blue pill for women, and add a unique twist of our own — as expected from readers. Read on in Health Research.
Mon, May 24, 2010
Post a Comment in
Body Image,
Health tagged
Boehringer Ingelheim,
female desire,
flibanserin 





















Reader Comments